Advertisement

Tumor Biology

, Volume 37, Issue 6, pp 7797–7808 | Cite as

Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature

  • Ning Qu
  • Ling Zhang
  • Zhong-wu Lu
  • Qing-hai Ji
  • Shu-wen Yang
  • Wen-jun Wei
  • Yan Zhang
Research Article

Abstract

The influence of predictors for recurrence in relation to recurrence-free survival was analyzed retrospectively in differentiated thyroid cancer (DTC) patients under 21 years of age who underwent primary surgical treatment and who had a pathological diagnosis of DTC between 1983 and 2012 at Fudan University Cancer Hospital. Recurrences were retrospectively analyzed using a Cox regression model for the hazard ratio (HR) according to the clinicopathological features. A meta-analysis was performed with respect to the potential predictors for recurrence from current related studies. In the present study, there were 146 young patients aged from 7 to 20 years, with a female/male ratio of 2.65/1. Female gender was the only factor significantly associated with recurrence according to univariate (HR = 2.812, P = 0.037) and multivariate (HR = 4.107, P = 0.024) Cox regression analyses. Meta-analyses revealed that multifocality (HR = 1.91, P < 0.05) and presentation at diagnosis (HR = 1.39, P < 0.05) were highly associated with recurrence in young DTC patients. However, female gender and other factors, such as age (≤10 vs. 11–20 years), PTC (PTC vs. FTC), extrathyroidal extension, lymph node metastasis, total thyroidectomy (total vs. less than total), radioiodine therapy, and radiation history, were not associated with recurrence in young DTC patients. In conclusion, multifocality and presentation at diagnosis are strong predictive factors of recurrence in relation to recurrence-free survival. We recommend studies with larger sample sizes and longer follow-up to verify the influence of predictors for disease recurrence in young patients.

Keywords

Differentiated thyroid cancer (DTC) Young Recurrence Meta-analysis 

Notes

Acknowledgments

This research is supported by grants from the National Natural Science Foundation of China (81272934) and the Natural Science Foundation of Shanghai (12ZR1406800).

Conflicts of interest

None

References

  1. 1.
    Kiratli PO, Volkan-Salanci B, Gunay EC, Varan A, Akyuz C, Buyukpamukcu M. Thyroid cancer in pediatric age group: an institutional experience and review of the literature. J Pediatr Hematol Oncol. 2013;35:93–7.CrossRefPubMedGoogle Scholar
  2. 2.
    Chaukar DA, Rangarajan V, Nair N, Dcruz AK, Nadkarni MS, Pai PS, et al. Pediatric thyroid cancer. J Surg Oncol. 2005;92:130–3.CrossRefPubMedGoogle Scholar
  3. 3.
    Hung W, Sarlis NJ. Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review. Thyroid. 2002;12:683–702.CrossRefPubMedGoogle Scholar
  4. 4.
    Kundel A, Thompson GB, Richards ML, Qiu LX, Cai Y, Schwenk FW, et al. Pediatric endocrine surgery: a 20-year experience at the mayo clinic. J Clin Endocrinol Metab. 2014;99:399–406.CrossRefPubMedGoogle Scholar
  5. 5.
    Zhou Y, Kundel A, Pittock ST, Thompson GB: Advanced presentation of paediatric papillary thyroid cancer: a plea for heightened awareness. J Paediatr Child Health. 2013.Google Scholar
  6. 6.
    Hay ID, Gonzalez-Losada T, Reinalda MS, Honetschlager JA, Richards ML, Thompson GB. Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg. 2010;34:1192–202.CrossRefPubMedGoogle Scholar
  7. 7.
    Dinauer C, Francis GL. Thyroid cancer in children. Endocrinol Metab Clin North Am. 2007;36:779–806. vii.CrossRefPubMedGoogle Scholar
  8. 8.
    Grigsby PW, Gal-or A, Michalski JM, Doherty GM. Childhood and adolescent thyroid carcinoma. Cancer. 2002;95:724–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Welch Dinauer CA, Tuttle RM, Robie DK, McClellan DR, Svec RL, Adair C, et al. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol (Oxf). 1998;49:619–28.CrossRefGoogle Scholar
  10. 10.
    Vassilopoulou-Sellin R, Goepfert H, Raney B, Schultz PN. Differentiated thyroid cancer in children and adolescents: clinical outcome and mortality after long-term follow-up. Head Neck. 1998;20:549–55.CrossRefPubMedGoogle Scholar
  11. 11.
    Borson-Chazot F, Causeret S, Lifante JC, Augros M, Berger N, Peix JL. Predictive factors for recurrence from a series of 74 children and adolescents with differentiated thyroid cancer. World J Surg. 2004;28:1088–92.CrossRefPubMedGoogle Scholar
  12. 12.
    Jarzab B, Handkiewicz Junak D, Wloch J, Kalemba B, Roskosz J, Kukulska A, et al. Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children. Eur J Nucl Med. 2000;27:833–41.CrossRefPubMedGoogle Scholar
  13. 13.
    Capurso G, Festa S, Valente R, Piciucchi M, Panzuto F, Jensen RT, et al. Molecular pathology and genetics of pancreatic endocrine tumours. J Mol Endocrinol. 2012;49:R37–50.CrossRefPubMedGoogle Scholar
  14. 14.
    Shah JP. Cervical lymph node metastases—diagnostic, therapeutic, and prognostic implications. Oncology (Williston Park). 1990;4:61–9. discussion 72, 76.Google Scholar
  15. 15.
    Edge SB, Compton CC. The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4.CrossRefPubMedGoogle Scholar
  16. 16.
    Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237:399–407.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Gill RD. Multistate life-tables and regression models. Math Popul Stud. 1992;3:259–76.CrossRefPubMedGoogle Scholar
  18. 18.
    Dinse GE, Lagakos SW. Nonparametric estimation of lifetime and disease onset distributions from incomplete observations. Biometrics. 1982;38:921–32.CrossRefPubMedGoogle Scholar
  19. 19.
    Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163–70.PubMedGoogle Scholar
  20. 20.
    Wells GA. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000.Google Scholar
  21. 21.
    Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Demidchik YE, Demidchik EP, Reiners C, Biko J, Mine M, Saenko VA, et al. Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of belarus. Ann Surg. 2006;243:525–32.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Palmer BA, Zarroug AE, Poley RN, Kollars JP, Moir CR. Papillary thyroid carcinoma in children: risk factors and complications of disease recurrence. J Pediatr Surg. 2005;40:1284–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Landau D, Vini L, A'Hern R, Harmer C. Thyroid cancer in children: the royal marsden hospital experience. Eur J Cancer. 2000;36:214–20.CrossRefPubMedGoogle Scholar
  26. 26.
    Farahati J, Parlowsky T, Mader U, Reiners C, Bucsky P. Differentiated thyroid cancer in children and adolescents. Langenbecks Arch Surg. 1998;383:235–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Park S, Jeong JS, Ryu HR, Lee CR, Park JH, Kang SW, et al. Differentiated thyroid carcinoma of children and adolescents: 27-year experience in the Yonsei University Health System. J Korean Med Sci. 2013;28:693–9.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Chow SM, Law SC, Mendenhall WM, Au SK, Yau S, Mang O, et al. Differentiated thyroid carcinoma in childhood and adolescence—clinical course and role of radioiodine. Pediatr Blood Cancer. 2004;42:176–83.CrossRefPubMedGoogle Scholar
  29. 29.
    La Quaglia MP, Black T, Holcomb 3rd GW, Sklar C, Azizkhan RG, Haase GM, et al. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the surgical discipline committee of the children's cancer group. J Pediatr Surg. 2000;35:955–9. discussion 960.CrossRefPubMedGoogle Scholar
  30. 30.
    Newman KD, Black T, Heller G, Azizkhan RG, Holcomb 3rd GW, Sklar C, et al. Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group. Ann Surg. 1998;227:533–41.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Hogan AR, Zhuge Y, Perez EA, Koniaris LG, Lew JI, Sola JE. Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res. 2009;156:167–72.CrossRefPubMedGoogle Scholar
  32. 32.
    Zimmerman D, Hay ID, Gough IR, Goellner JR, Ryan JJ, Grant CS, et al. Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery. 1988;104:1157–66.PubMedGoogle Scholar
  33. 33.
    Massimino M, Gasparini M, Ballerini E, Del Bo R. Primary thyroid carcinoma in children: a retrospective study of 20 patients. Med Pediatr Oncol. 1995;24:13–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Massimino M, Collini P, Leite SF, Spreafico F, Zucchini N, Ferrari A, et al. Conservative surgical approach for thyroid and lymph-node involvement in papillary thyroid carcinoma of childhood and adolescence. Pediatr Blood Cancer. 2006;46:307–13.CrossRefPubMedGoogle Scholar
  35. 35.
    Collini P, Massimino M, Leite SF, Mattavelli F, Seregni E, Zucchini N, et al. Papillary thyroid carcinoma of childhood and adolescence: a 30-year experience at the istituto nazionale tumori in milan. Pediatr Blood Cancer. 2006;46:300–6.CrossRefPubMedGoogle Scholar
  36. 36.
    Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007;246:375–81. discussion 381-374.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Alzahrani AS, Al Mandil M, Chaudhary MA, Ahmed M, Mohammed GE. Frequency and predictive factors of malignancy in residual thyroid tissue and cervical lymph nodes after partial thyroidectomy for differentiated thyroid cancer. Surgery. 2002;131:443–9.CrossRefPubMedGoogle Scholar
  38. 38.
    Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med. 1981;70:511–8.CrossRefPubMedGoogle Scholar
  39. 39.
    Fenton CL, Lukes Y, Nicholson D, Dinauer CA, Francis GL, Tuttle RM. The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. J Clin Endocrinol Metab. 2000;85:1170–5.PubMedGoogle Scholar
  40. 40.
    Thompson GB, Hay ID. Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma. World J Surg. 2004;28:1187–98.CrossRefPubMedGoogle Scholar
  41. 41.
    Friedman M, Pacella Jr BL. Total versus subtotal thyroidectomy. Arguments, approaches, and recommendations. Otolaryngol Clin North Am. 1990;23:413–27.PubMedGoogle Scholar
  42. 42.
    Sosa JA, Tuggle CT, Wang TS, Thomas DC, Boudourakis L, Rivkees S, et al. Clinical and economic outcomes of thyroid and parathyroid surgery in children. J Clin Endocrinol Metab. 2008;93:3058–65.CrossRefPubMedGoogle Scholar
  43. 43.
    Haveman JW, van Tol KM, Rouwe CW, Piers DA, Plukker JT. Surgical experience in children with differentiated thyroid carcinoma. Ann Surg Oncol. 2003;10:15–20.CrossRefPubMedGoogle Scholar
  44. 44.
    Bargren AE, Meyer-Rochow GY, Delbridge LW, Sidhu SB, Chen H. Outcomes of surgically managed pediatric thyroid cancer. J Surg Res. 2009;156:70–3.CrossRefPubMedGoogle Scholar
  45. 45.
    Kowalski LP, Goncalves Filho J, Pinto CA, Carvalho AL, de Camargo B. Long-term survival rates in young patients with thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129:746–9.CrossRefPubMedGoogle Scholar
  46. 46.
    Giuffrida D, Scollo C, Pellegriti G, Lavenia G, Iurato MP, Pezzin V, et al. Differentiated thyroid cancer in children and adolescents. J Endocrinol Invest. 2002;25:18–24.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Ning Qu
    • 1
    • 2
  • Ling Zhang
    • 1
    • 2
  • Zhong-wu Lu
    • 1
    • 2
  • Qing-hai Ji
    • 1
    • 2
  • Shu-wen Yang
    • 1
    • 2
  • Wen-jun Wei
    • 1
    • 2
  • Yan Zhang
    • 1
    • 2
  1. 1.Department of Head and Neck SurgeryFudan University Shanghai Cancer CenterShanghaiChina
  2. 2.Department of Oncology, Shanghai Medical CollegeFudan UniversityShanghaiChina

Personalised recommendations